Le Lézard
Classified in: Health
Subject: SVY

Global Injectable Drugs Delivery Industry


NEW YORK, Jan. 20, 2020 /PRNewswire/ --

Injectable Drugs Delivery market worldwide is projected to grow by US$423.4 Billion, driven by a compounded growth of 11%. Device, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$172.8 Billion by the year 2025, Device will bring in healthy gains adding significant momentum to global growth.

Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

- Representing the developed world, the United States will maintain a 12.5% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$20.1 Billion to the region's size and clout in the next 5 to 6 years. Over US$19.4 Billion worth of projected demand in the region will come from Rest of Europe markets. In Japan, Device will reach a market size of US$17 Billion by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 10.7% over the next couple of years and add approximately US$73.8 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others, Baxter International, Inc.; Becton, Dickinson and Company; Elcam Medical; Eli Lilly and Company; Gerresheimer AG; INJEX Pharma GmbH; Novartis International AG; Novo Nordisk A/S; SCHOTT AG; Terumo Corporation; Teva Pharmaceuticals USA, Inc.; West Pharmaceutical Services, Inc.



Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Injectable Drugs Delivery Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Injectable Drugs Delivery Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2018-2025
Table 2: Injectable Drugs Delivery Global Retrospective Market
Scenario in US$ Million by Region/Country: 2009-2017
Table 3: Injectable Drugs Delivery Market Share Shift across
Key Geographies Worldwide: 2009 VS 2019 VS 2025
Table 4: Device (Segment) World Market by Region/Country in US$
Million: 2018 to 2025
Table 5: Device (Segment) Historic Market Analysis by
Region/Country in US$ Million: 2009 to 2017
Table 6: Device (Segment) Market Share Breakdown of Worldwide
Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Formulation (Segment) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Formulation (Segment) Historic Market Perspective by
Region/Country in US$ Million: 2009 to 2017
Table 9: Formulation (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Hospitals & Clinics (End-Use) Global Market Estimates
& Forecasts in US$ Million by Region/Country: 2018-2025
Table 11: Hospitals & Clinics (End-Use) Retrospective Demand
Analysis in US$ Million by Region/Country: 2009-2017
Table 12: Hospitals & Clinics (End-Use) Market Share Breakdown
by Region/Country: 2009 VS 2019 VS 2025
Table 13: Home Care (End-Use) Demand Potential Worldwide in US$
Million by Region/Country: 2018-2025
Table 14: Home Care (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2009-2017
Table 15: Home Care (End-Use) Share Breakdown Review by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Research Laboratories (End-Use) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2018-2025
Table 17: Research Laboratories (End-Use) Global Historic
Analysis in US$ Million by Region/Country: 2009-2017
Table 18: Research Laboratories (End-Use) Distribution of
Global Sales by Region/Country: 2009 VS 2019 VS 2025
Table 19: Other End-Uses (End-Use) Sales Estimates and
Forecasts in US$ Million by Region/Country for the Years 2018
through 2025
Table 20: Other End-Uses (End-Use) Analysis of Historic Sales
in US$ Million by Region/Country for the Years 2009 to 2017
Table 21: Other End-Uses (End-Use) Global Market Share
Distribution by Region/Country for 2009, 2019, and 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Injectable Drugs Delivery Market Share (in %) by Company:
2019 & 2025
Table 22: United States Injectable Drugs Delivery Market
Estimates and Projections in US$ Million by Segment: 2018 to
2025
Table 23: Injectable Drugs Delivery Market in the United States
by Segment: A Historic Review in US$ Million for 2009-2017
Table 24: United States Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 25: United States Injectable Drugs Delivery Latent Demand
Forecasts in US$ Million by End-Use: 2018 to 2025
Table 26: Injectable Drugs Delivery Historic Demand Patterns in
the United States by End-Use in US$ Million for 2009-2017
Table 27: Injectable Drugs Delivery Market Share Breakdown in
the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
Table 28: Canadian Injectable Drugs Delivery Market Estimates
and Forecasts in US$ Million by Segment: 2018 to 2025
Table 29: Canadian Injectable Drugs Delivery Historic Market
Review by Segment in US$ Million: 2009-2017
Table 30: Injectable Drugs Delivery Market in Canada:
Percentage Share Breakdown of Sales by Segment for 2009, 2019,
and 2025
Table 31: Canadian Injectable Drugs Delivery Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 32: Injectable Drugs Delivery Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 33: Canadian Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
Table 34: Japanese Market for Injectable Drugs Delivery: Annual
Sales Estimates and Projections in US$ Million by Segment for
the Period 2018-2025
Table 35: Injectable Drugs Delivery Market in Japan: Historic
Sales Analysis in US$ Million by Segment for the Period
2009-2017
Table 36: Japanese Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 37: Japanese Demand Estimates and Forecasts for
Injectable Drugs Delivery in US$ Million by End-Use: 2018 to
2025
Table 38: Japanese Injectable Drugs Delivery Market in US$
Million by End-Use: 2009-2017
Table 39: Injectable Drugs Delivery Market Share Shift in Japan
by End-Use: 2009 VS 2019 VS 2025
CHINA
Table 40: Chinese Injectable Drugs Delivery Market Growth
Prospects in US$ Million by Segment for the Period 2018-2025
Table 41: Injectable Drugs Delivery Historic Market Analysis in
China in US$ Million by Segment: 2009-2017
Table 42: Chinese Injectable Drugs Delivery Market by Segment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 43: Chinese Demand for Injectable Drugs Delivery in US$
Million by End-Use: 2018 to 2025
Table 44: Injectable Drugs Delivery Market Review in China in
US$ Million by End-Use: 2009-2017
Table 45: Chinese Injectable Drugs Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Injectable Drugs Delivery Market: Competitor Market
Share Scenario (in %) for 2019 & 2025
Table 46: European Injectable Drugs Delivery Market Demand
Scenario in US$ Million by Region/Country: 2018-2025
Table 47: Injectable Drugs Delivery Market in Europe: A
Historic Market Perspective in US$ Million by Region/Country
for the Period 2009-2017
Table 48: European Injectable Drugs Delivery Market Share Shift
by Region/Country: 2009 VS 2019 VS 2025
Table 49: European Injectable Drugs Delivery Market Estimates
and Forecasts in US$ Million by Segment: 2018-2025
Table 50: Injectable Drugs Delivery Market in Europe in US$
Million by Segment: A Historic Review for the Period 2009-2017
Table 51: European Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 52: European Injectable Drugs Delivery Addressable Market
Opportunity in US$ Million by End-Use: 2018-2025
Table 53: Injectable Drugs Delivery Market in Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 54: European Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
Table 55: Injectable Drugs Delivery Market in France by
Segment: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 56: French Injectable Drugs Delivery Historic Market
Scenario in US$ Million by Segment: 2009-2017
Table 57: French Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 58: Injectable Drugs Delivery Quantitative Demand
Analysis in France in US$ Million by End-Use: 2018-2025
Table 59: French Injectable Drugs Delivery Historic Market
Review in US$ Million by End-Use: 2009-2017
Table 60: French Injectable Drugs Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
GERMANY
Table 61: Injectable Drugs Delivery Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Segment for
the Period 2018-2025
Table 62: German Injectable Drugs Delivery Historic Market
Analysis in US$ Million by Segment: 2009-2017
Table 63: German Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 64: Injectable Drugs Delivery Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2018-2025
Table 65: German Injectable Drugs Delivery Market in Retrospect
in US$ Million by End-Use: 2009-2017
Table 66: Injectable Drugs Delivery Market Share Distribution
in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
Table 67: Italian Injectable Drugs Delivery Market Growth
Prospects in US$ Million by Segment for the Period 2018-2025
Table 68: Injectable Drugs Delivery Historic Market Analysis in
Italy in US$ Million by Segment: 2009-2017
Table 69: Italian Injectable Drugs Delivery Market by Segment:
Percentage Breakdown of Sales for 2009, 2019, and 2025
Table 70: Italian Demand for Injectable Drugs Delivery in US$
Million by End-Use: 2018 to 2025
Table 71: Injectable Drugs Delivery Market Review in Italy in
US$ Million by End-Use: 2009-2017
Table 72: Italian Injectable Drugs Delivery Market Share
Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
Table 73: United Kingdom Market for Injectable Drugs Delivery:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2018-2025
Table 74: Injectable Drugs Delivery Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Segment for
the Period 2009-2017
Table 75: United Kingdom Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 76: United Kingdom Demand Estimates and Forecasts for
Injectable Drugs Delivery in US$ Million by End-Use: 2018 to
2025
Table 77: United Kingdom Injectable Drugs Delivery Market in
US$ Million by End-Use: 2009-2017
Table 78: Injectable Drugs Delivery Market Share Shift in the
United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 79: Rest of Europe Injectable Drugs Delivery Market
Estimates and Forecasts in US$ Million by Segment: 2018-2025
Table 80: Injectable Drugs Delivery Market in Rest of Europe in
US$ Million by Segment: A Historic Review for the Period
2009-2017
Table 81: Rest of Europe Injectable Drugs Delivery Market Share
Breakdown by Segment: 2009 VS 2019 VS 2025
Table 82: Rest of Europe Injectable Drugs Delivery Addressable
Market Opportunity in US$ Million by End-Use: 2018-2025
Table 83: Injectable Drugs Delivery Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2009-2017
Table 84: Rest of Europe Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 85: Injectable Drugs Delivery Market in Asia-Pacific by
Segment: Estimates and Projections in US$ Million for the
Period 2018-2025
Table 86: Asia-Pacific Injectable Drugs Delivery Historic
Market Scenario in US$ Million by Segment: 2009-2017
Table 87: Asia-Pacific Injectable Drugs Delivery Market Share
Analysis by Segment: 2009 VS 2019 VS 2025
Table 88: Injectable Drugs Delivery Quantitative Demand
Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
Table 89: Asia-Pacific Injectable Drugs Delivery Historic
Market Review in US$ Million by End-Use: 2009-2017
Table 90: Asia-Pacific Injectable Drugs Delivery Market Share
Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and
2025
REST OF WORLD
Table 91: Rest of World Injectable Drugs Delivery Market
Estimates and Forecasts in US$ Million by Segment: 2018 to 2025
Table 92: Rest of World Injectable Drugs Delivery Historic
Market Review by Segment in US$ Million: 2009-2017
Table 93: Injectable Drugs Delivery Market in Rest of World:
Percentage Share Breakdown of Sales by Segment for 2009, 2019,
and 2025
Table 94: Rest of World Injectable Drugs Delivery Market
Quantitative Demand Analysis in US$ Million by End-Use: 2018 to
2025
Table 95: Injectable Drugs Delivery Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2009-2017
Table 96: Rest of World Injectable Drugs Delivery Market Share
Analysis by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

BAXTER INTERNATIONAL
ELCAM MEDICAL
ELI LILLY AND COMPANY
GERRESHEIMER AG
INJEX PHARMA GMBH
NOVARTIS INTERNATIONAL AG
NOVO NORDISK A/S
SCHOTT AG
TERUMO CORPORATION
TEVA PHARMACEUTICALS USA
WEST PHARMACEUTICAL SERVICES

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05798896/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: